DUNCAN DARNELL: Open Payments
NPI 1003809997 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,682 in 91 payments from 12 companies in 2025. Trend: 2023 $955 · 2024 $1,208 · 2025 $1,682
Food & beverage: $1,682
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 21 | $330 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $282 |
| Neurocrine BioSciences, Inc. | 9 | $185 |
| Alkermes, Inc. | 9 | $180 |
| Otsuka America Pharmaceutical, Inc. | 8 | $161 |
| Corium, LLC | 12 | $156 |
| Lundbeck LLC | 5 | $110 |
| Axsome Therapeutics, Inc. | 5 | $103 |
| Vanda Pharmaceuticals Inc. | 3 | $83 |
| Teva Pharmaceuticals USA, Inc. | 2 | $43 |
Products named: COBENFY, CAPLYTA, INGREZZA, REXULTI, Azstarys, ARISTADA, Auvelity, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
